查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1843742

2025年全球醫療保健人工智慧市場報告

Artificial Intelligence in Healthcare Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧在醫療保健領域的市場規模呈指數級成長，從2024年的181.6億美元成長到2025年的241億美元，複合年成長率達32.7%。這一成長可歸因於合作與夥伴關係的增加、慢性病患病率的上升、人工智慧在放射學領域的應用日益廣泛、人工智慧在經濟高效的藥物研發中的應用日益廣泛，以及醫療保健領域人工智慧資金籌措的不斷增加。

預計未來幾年，醫療保健領域的人工智慧市場將呈指數級成長，到2029年市場規模將達到720.3億美元，複合年成長率（CAGR）為31.5%。預測期內的成長可歸因於老年人口的成長、醫療保健領域數位轉型的年複合成長率以及政府措施。預測期內的關鍵趨勢包括：人工智慧在臨床試驗中的應用、人工智慧在罕見疾病治療中的應用、人工智慧在藥物依從性方面的應用、人工智慧在標靶選擇中的應用、人工智慧模型在臨床前試驗中的應用、對人工智慧主導生物技術公司的投資、併購活動的增加、合約研究組織（CRO）在人工智慧生態系統中日益重要的作用、人工智慧生態系統中日益重要的作用、

醫療保健領域的人工智慧是指利用機器學習和認知演算法來改善治療和患者療效，並應用於各種醫療保健領域，包括醫學診斷、藥物發現、臨床試驗、疼痛管理和患者整體改善。

醫療保健領域的人工智慧產品主要包括硬體和軟體。這些產品運用多種演算法，包括深度學習、查詢方法、自然語言處理和上下文感知處理。醫療設備製造商正利用人工智慧技術創新其硬體產品，以輔助醫療服務提供者並提升治療效果。科技公司則專注於開發適用於醫療保健解決方案的人工智慧演算法。人工智慧在醫療保健領域的應用範圍廣泛，包括機器人輔助手術、虛擬護理助理、行政工作流程支援、詐欺檢測、減少用藥錯誤、臨床試驗參與者識別和初步診斷。人工智慧在醫療保健領域的主要用戶包括醫院、診斷中心、製藥和生物製藥公司、醫療保險機構以及個人患者。

美國在2025年春季突然提高關稅及其引發的貿易摩擦，對資訊科技產業，特別是硬體製造、資料基礎設施和軟體部署領域，產生了重大影響。進口半導體、電路基板和網路設備的關稅上漲，推高了高科技公司、雲端服務供應商和資料中心的生產和營運成本。在全球範圍內採購筆記型電腦、伺服器和消費電子產品零件的公司，面臨更長的前置作業時間和價格壓力。同時，對專用軟體徵收的關稅以及主要國際市場的報復性措施，擾亂了全球IT供應鏈，並降低了海外對美國製造技術的需求。為了應對這些挑戰，該產業正在加大對國內晶片生產的投資，擴大供應商網路，並利用人工智慧驅動的自動化技術來增強韌性，更有效地控制成本。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，該系列報告提供有關醫療保健領域人工智慧的市場統計數據，包括全球市場規模、區域佔有率、醫療保健領域人工智慧市場佔有率的競爭對手、詳細的醫療保健領域人工智慧市場細分、市場趨勢和商業機會，為您提供在醫療保健領域人工智慧行業取得成功所需的數據。這份醫療保健領域人工智慧市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析，為您提供全面的觀點，滿足您的所有需求。

未來五年31.5%的成長預測較我們先前對該市場的預測略微下調了0.3%。這一下調主要歸因於美國與其他國家之間的關稅影響。由於從德國和日本主要供應商採購的診斷硬體和軟體系統需繳納關稅，醫療服務提供者在採用人工智慧方面可能會遇到延誤。此外，由於相互關稅措施以及貿易緊張局勢和限制升級對全球經濟和貿易造成的負面影響，這種影響也將更加廣泛。

精準醫療的日益普及是推動人工智慧融入醫療保健市場的主要動力。精準醫療利用個體的基因資訊以及環境和生活方式因素，為患者量身定做診斷和治療方案。它在腫瘤學領域尤其普遍，隨著癌症發生率的上升，精準醫療領域對人工智慧的需求預計將會增加。例如，總部位於美國的非營利組織「個人化醫療聯盟」（Personalized Medicine Coalition）在2024年2月報告稱，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病患者的個人化治療方案，高於2022年的6種。因此，精準醫療的廣泛應用正在推動人工智慧醫療保健市場的成長。

各國政府加強對醫療保健領域人工智慧的支持舉措，預計將推動人工智慧醫療保健市場的成長。印度和中國等國已推出多項旨在加強人工智慧在醫療保健領域應用的舉措。例如，2022年4月，印度政府專注於利用人工智慧監測全國範圍內的疾病爆發。目前，印度政府正與國家疾病管制中心（NCDC）合作開發一款工具，該工具將掃描與健康相關的媒體通報，建立資料庫，追蹤綜合疾病監測計畫（IDSP）下監測的33種疾病，其中一些疾病可能具有流行潛力。此外，2022年9月，美國國立衛生研究院（NIH）——一家專注於醫學研究的聯邦機構——推出了Bridge2AI計劃，將在四年內投資1.3億美元，以促進人工智慧在生物醫學和行為科學領域的應用。該舉措，預計將推動市場成長。

醫療保健人工智慧 (AI) 市場的參與者正在密切關注創新 AI 工具的應用，這些工具將為製藥公司帶來顯著效益。一些知名公司正在策略性地將新型 AI 工具引入藥物研發領域。領先企業內部的科學研究團隊正積極開發新型工具，以協助全球新冠肺炎治療藥物的研發。例如，Aster DM 醫療集團的創新中心 Aster 創新與研究中心於 2022 年 7 月與英特爾公司和 AI 平台供應商 CARPL.ai 合作，在印度建立了一個 AI 驅動的健康數據平台。

製藥和生物製藥公司正積極收購在資料科學和人工智慧領域擁有專長的公司。這種策略性措施旨在透過增強決策流程、最佳化研究和臨床試驗效率，以及為包括醫生、消費者、保險公司和監管機構在內的利害關係人相關人員，來推動醫療保健產業的創新。 2022年1月，固定門診影像服務供應商RadNet收購了放射學人工智慧公司Aidence，該公司專注於為肺結節管理和肺癌篩檢提供人工智慧臨床解決方案。 2022年2月，領先的遠距皮膚科服務供應商OnlineDoctor收購了德國新創新興企業ASSIST（Automated Scientific Skin Infection Search Technology），該公司在皮膚病學人工智慧領域擁有豐富的經驗，從而擴展了自身的服務能力。 OnlineDoctor是歐洲領先的遠距皮膚病學服務供應商，與皮膚科醫生、藥局、醫院和健康保險公司合作，並在瑞士、德國和奧地利設有辦公室。

2024年9月，美國醫療科技公司史賽克（Stryker Corporation）宣布將收購care.ai，具體金額未揭露。此次收購旨在透過將先進的人工智慧輔助虛擬醫療解決方案融入史賽克的產品和服務，強化其數位化醫療策略。史賽克希望透過增強其在智慧病房技術和環境智慧的專業能力，改善即時決策工具，從而更好地支持醫療服務提供者並改善患者的治療效果。 care.ai是一家總部位於美國的科技公司，專注於人工智慧主導的醫療解決方案。

在醫療保健人工智慧市場中營運的主要公司包括：IBM Watson Health、Nuance Communications, Inc、Alphabet Inc、Concreto HealthAI、Nvidia Corporation、PathAI、XtalPi、Benevolent AI、Exscientia、OWKIN、LiveHealth、ChironX、Consure Medicalem、Predible Health、Lybrate、Artelus、Oncodem Qure.ai、嘉興泰美醫療科技股份有限公司、平安健康醫療科技股份有限公司、依圖醫療、iCarbonX、Insilico、Skin Analytics、Babylon Health、Cambridge Cognition、Renalytix AI、Iktos、諾華、Gero、Ardigen、Botkin、Webiomed、Medutor AI、Diagnocat、Atomise、Enagno、Atomc​​yia、Aconc​​hi​​oo 你） Pharmaceuticals、Verge Genomics、Berg LLC、Deep Genomics、Cyclica、IQVIA、羅氏、輝瑞、PRA Healthscience、Gesto、Intensicare。 Discience、Betterfly、Deenty、Examedi、Dentalink、Cero、MedPass、Pixeon、Hi Technologies、Conexa Saude、Wuru、Yerbo、Bioscience、Caecus、Epitrack、GE Healthcare、Oncora Medical、Recursion Pharmaceuticals Inc、Nucle、Pepticom、AstraiY、Rt.

2024年，北美是醫療保健領域人工智慧市場最大的區域。預計亞太地區將在預測期內成為成長最快的區域。這份醫療保健領域人工智慧市場報告涵蓋亞太地區、西歐、中東歐、北美、南美以及中東和非洲。

醫療保健人工智慧市場報告涵蓋的國家包括澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙和加拿大。

醫療保健領域的人工智慧市場包括營業單位透過發現基因密碼之間的關聯、驅動手術機器人以及提高醫院效率而獲得的收入。市場價值包括服務供應商銷售的或包含在服務產品中的相關商品的價值。它僅包括營業單位之間交易或出售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球醫療保健領域的人工智慧：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球醫療保健人工智慧市場：成長率分析
  • 全球醫療保健人工智慧市場表現：規模與成長，2019-2024年
  • 全球醫療保健人工智慧市場預測：規模和成長，2024-2029年，2034年
  • 醫療保健領域的人工智慧：全球潛在市場規模 (TAM)

第6章 市場細分

  • 全球醫療保健人工智慧市場：依產品、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 硬體
  • 軟體
  • 服務
  • 全球醫療保健領域人工智慧市場：依演算法、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 深度學習
  • 查詢方法
  • 自然語言處理
  • 情境感知處理
  • 全球醫療保健領域人工智慧市場：按應用、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 機器人輔助手術
  • 虛擬護理助理
  • 管理工作流程支持
  • 詐欺偵測
  • 減少劑量誤差
  • 臨床試驗參與者識別符
  • 初步診斷
  • 全球醫療保健人工智慧市場按最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 醫院和診斷中心
  • 製藥和生物製藥公司
  • 醫療保健支付方
  • 病人
  • 全球醫療保健人工智慧市場：按硬體（類型）、效能和預測進行細分，2019-2024年、2024-2029年、2034年
  • 人工智慧成像設備
  • 穿戴式健康監測設備
  • 機器人和手術設備
  • 全球醫療保健人工智慧市場：按軟體類型、效能和預測細分，2019-2024年、2024-2029年、2034年
  • 診斷軟體
  • 預測分析軟體
  • 自然語言處理（NLP）軟體
  • 全球醫療保健人工智慧市場：按服務類型、效能和預測細分，2019-2024年、2024-2029年、2034年
  • 諮詢服務
  • 實施服務
  • 維護和支援服務

第7章 區域和國家分析

  • 全球醫療保健人工智慧市場：區域表現與預測，2019-2024年、2024-2029年、2034年
  • 全球醫療保健人工智慧市場：國家、表現與預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工智慧在醫療保健領域的應用：競爭格局
  • 醫療保健領域的人工智慧市場：公司概況
    • IBM Watson Health Overview, Products and Services, Strategy and Financial Analysis
    • Nuance Communications, Inc Overview, Products and Services, Strategy and Financial Analysis
    • Alphabet Inc Overview, Products and Services, Strategy and Financial Analysis
    • Concreto HealthAI Overview, Products and Services, Strategy and Financial Analysis
    • Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • PathAI
  • XtalPi
  • Benevolent AI
  • Exscientia
  • OWKIN
  • LiveHealth
  • ChironX
  • Consure Medical
  • Predible Health
  • Lybrate
  • Artelus
  • OncoStem Qure.ai
  • Jiaxing Taimei Medical Technology
  • Ping An Health Medical Technology
  • YITU

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年醫療保健領域人工智慧市場：提供新機會的國家
  • 2029年醫療保健領域的人工智慧：充滿新機會的細分市場
  • 2029 年醫療保健領域的人工智慧：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r25465u

AI in healthcare denotes the utilization of machine learning and cognitive algorithms to enhance treatment methods and patient outcomes. It finds application across various healthcare facets such as medical diagnostics, drug discovery, clinical trials, pain management, and overall patient improvement.

AI in healthcare offerings primarily comprises hardware and software. Within these offerings, AI products leverage diverse algorithms including deep learning, querying methods, natural language processing, and context-aware processing. Medical device manufacturers harness AI-based technologies to innovate hardware products, aiding healthcare providers and enhancing treatments. Technology firms focus on developing AI algorithms tailored for healthcare solutions. The applications of AI in healthcare are widespread, encompassing robot-assisted surgery, virtual nursing aides, support in administrative workflows, fraud detection, dosage error reduction, identification of clinical trial participants, and preliminary diagnoses. Key users of AI in healthcare span hospitals, diagnostic centers, pharmaceutical and biopharmaceutical companies, healthcare payers, and individual patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The Artificial Intelligence in healthcare market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in healthcare market statistics, including artificial intelligence in healthcare industry global market size, regional shares, competitors with artificial intelligence in healthcare market share, detailed artificial intelligence in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in healthcare industry. This artificial intelligence in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in healthcare market size has grown exponentially in recent years. It will grow from $18.16 billion in 2024 to $24.1 billion in 2025 at a compound annual growth rate (CAGR) of 32.7%. The growth in the historic period can be attributed to growing number of collaborations and partnerships, rising prevalence of chronic diseases, increasing implementation of AI in radiology, the growing adoption of artificial intelligence for cost-efficient drug discovery, and rising funding in artificial intelligence in healthcare.

The artificial intelligence in healthcare market size is expected to see exponential growth in the next few years. It will grow to $72.03 billion in 2029 at a compound annual growth rate (CAGR) of 31.5%. The growth in the forecast period can be attributed to an increase in the geriatric population, the growing adoption of digital transformation in healthcare, and increasing government initiatives for supporting artificial intelligence in healthcare. Major trends in the forecast period include the use of AI for clinical trials, AI for rare diseases treatment, AI for drug adherence, AI in target selection, leveraging AI-based models in pre-clinical studies, investments in AI-driven biotech firms, rise in merger and acquisition activity, the emerging role of CROs in AI ecosystems, the introduction of new artificial intelligence (AI) tools, the introduction of AI innovation labs.

The forecast of 31.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Healthcare providers may see delays in AI adoption due to tariffs on diagnostic hardware and software systems sourced from leading suppliers in Germany and Japan. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing adoption of precision medicine is a key driving factor for the integration of artificial intelligence in the healthcare market. Precision medicine utilizes information about an individual's genetics, along with environmental and lifestyle factors, to tailor diagnoses and therapies for patients. It is particularly prevalent in oncology, and as the incidence of cancer rises, the demand for AI in precision medicine is expected to increase. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, up from six in 2022. Consequently, the rise in precision medicine adoption is propelling growth in the artificial intelligence healthcare market.

The rise in government initiatives to support artificial intelligence in healthcare is anticipated to drive growth in the AI healthcare market. Countries like India and China are launching various initiatives aimed at enhancing AI applications in healthcare. For example, in April 2022, the Indian government focused on leveraging AI to monitor disease outbreaks across the country. A tool currently being developed in collaboration with the National Centre for Disease Control (NCDC) will scan health-related media reports to create a database tracking 33 diseases monitored under the Integrated Disease Surveillance Programme (IDSP), some of which have epidemic potential. Additionally, in September 2022, the National Institutes of Health (NIH), a U.S.-based federal agency dedicated to medical research, introduced the Bridge2AI program, investing $130 million over four years to advance the use of AI in biomedical and behavioral research. This initiative aims to create ethically sourced, AI-ready datasets and standards by bringing together diverse research teams. Therefore, the increase in government initiatives supporting artificial intelligence in healthcare is expected to promote market growth.

Entities within the artificial intelligence (AI) for the healthcare market are observing the introduction of innovative AI tools with significant benefits for pharmaceutical companies. Prominent corporations are strategically launching new AI-enabled tools in the drug discovery sector. Scientific communities within major enterprises are diligently developing novel tools to contribute to the global efforts in COVID-19 treatment development. In a notable example, the Aster Innovation and Research Centre, the innovation hub of the Aster DM Healthcare Group, collaborated with Intel Corporation and AI platform provider CARPL.ai in July 2022 to create an AI-powered health data platform in India.

Pharmaceutical and biopharmaceutical companies are actively pursuing acquisitions of firms possessing expertise in data science and AI. This strategic approach aims to drive innovation within the healthcare industry by enhancing decision-making processes, optimizing research and clinical trials efficiency, and creating valuable tools for stakeholders such as physicians, consumers, insurers, and regulators. In January 2022, RadNet, a provider of fixed-site outpatient diagnostic imaging services, acquired Aidence, a radiology AI company specializing in AI-enabled clinical solutions for pulmonary nodule management and lung cancer screening. In February 2022, OnlineDoctor, a leading teledermatology provider, expanded its capabilities by acquiring A.S.S.I.S.T (Automated Scientific Skin Infection Search Technology), a German startup with expertise in AI for dermatology. OnlineDoctor operates as one of Europe's premier teledermatology providers, with a presence in Switzerland, Germany, and Austria, collaborating with dermatologists, pharmacies, hospitals, and health insurance companies.

In September 2024, Stryker Corporation, a U.S.-based medical technology firm, announced its acquisition of care.ai for an undisclosed sum. This acquisition is intended to strengthen Stryker's digital healthcare strategy by incorporating advanced AI-assisted virtual care solutions into its offerings. By enhancing its expertise in smart room technology and ambient intelligence, Stryker aims to improve real-time decision-making tools that assist healthcare providers and enhance patient care outcomes. Care.ai is a U.S.-based company that specializes in artificial intelligence-driven healthcare solutions.

Major companies operating in the artificial intelligence in healthcare market include IBM Watson Health, Nuance Communications, Inc, Alphabet Inc, Concreto HealthAI, Nvidia Corporation, PathAI, XtalPi, Benevolent AI, Exscientia, OWKIN, LiveHealth, ChironX, Consure Medical, Predible Health, Lybrate, Artelus, OncoStem Qure.ai, Jiaxing Taimei Medical Technology, Ping An Health Medical Technology, YITU, iCarbonX, Insilico, Skin Analytics, Babylon Health, Cambridge Cognition, Renalytix AI, Iktos, Novartis, Gero, Ardigen, Botkin, Webiomed, Care Mentor AI, Diagnocat, Atomwise Inc, Cloud Pharmaceuticals, Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica, IQVIA, Roche, Pfizer, PRA Healthscience, Gesto, Intensicare, Didoc, Betterfly, Deenty, Examedi, Dentalink, Cero, MedPass, Pixeon, Hi Technologies, Conexa Saude, Wuru, Yerbo, BioScience, Caecus, Epitrack, GE Healthcare, Oncora Medical, Recursion Pharmaceuticals Inc, Nucleai, Pepticom, AstraZeneca, Rology, HearX Group, DilenyTech, iNNOHEALTH Technology Solutions

North America was the largest region in the Artificial Intelligence in the Healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The AI in healthcare market includes revenues earned by entities by discovering links between genetic codes, powering surgical robots and maximizing hospital efficiency. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence in Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Offering: Hardware, Software, Services
  • 2) By Algorithm: Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing
  • 3) By Application: Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis
  • 4) By End-User: Hospitals And Diagnostic Centers, Pharmaceutical And Biopharmaceutical Companies, Healthcare Payers, Patients
  • Subsegments:
  • 1) By Hardware: AI-Powered Imaging Devices; Wearable Health Monitoring Devices; Robotics And Surgical Devices
  • 2) By Software: Diagnostic Software; Predictive Analytics Software; Natural Language Processing (NLP) Software
  • 3) By Services: Consulting Services; Implementation Services; Maintenance And Support Services
  • Companies Mentioned: IBM Watson Health; Nuance Communications, Inc; Alphabet Inc; Concreto HealthAI; Nvidia Corporation; PathAI; XtalPi; Benevolent AI; Exscientia; OWKIN; LiveHealth; ChironX; Consure Medical; Predible Health; Lybrate; Artelus; OncoStem Qure.ai; Jiaxing Taimei Medical Technology; Ping An Health Medical Technology; YITU; iCarbonX; Insilico; Skin Analytics; Babylon Health; Cambridge Cognition; Renalytix AI; Iktos; Novartis; Gero; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; Atomwise Inc; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Deep Genomics; Cyclica; IQVIA; Roche; Pfizer; PRA Healthscience; Gesto; Intensicare; Didoc; Betterfly; Deenty; Examedi; Dentalink; Cero; MedPass; Pixeon; Hi Technologies; Conexa Saude; Wuru; Yerbo; BioScience; Caecus; Epitrack; GE Healthcare; Oncora Medical; Recursion Pharmaceuticals Inc; Nucleai; Pepticom; AstraZeneca; Rology; HearX Group; DilenyTech; iNNOHEALTH Technology Solutions
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence in Healthcare Market Characteristics

3. Artificial Intelligence in Healthcare Market Trends And Strategies

4. Artificial Intelligence in Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence in Healthcare Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence in Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence in Healthcare Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence in Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence in Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence in Healthcare Total Addressable Market (TAM)

6. Artificial Intelligence in Healthcare Market Segmentation

  • 6.1. Global Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hardware
  • Software
  • Services
  • 6.2. Global Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Learning
  • Querying Method
  • Natural Language Processing
  • Context Aware Processing
  • 6.3. Global Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Robot-Assisted Surgery
  • Virtual Nursing Assistant
  • Administrative Workflow Assistance
  • Fraud Detection
  • Dosage Error Reduction
  • Clinical Trial Participant Identifier
  • Preliminary Diagnosis
  • 6.4. Global Artificial Intelligence in Healthcare Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Centers
  • Pharmaceutical And Biopharmaceutical Companies
  • Healthcare Payers
  • Patients
  • 6.5. Global Artificial Intelligence in Healthcare Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI-Powered Imaging Devices
  • Wearable Health Monitoring Devices
  • Robotics And Surgical Devices
  • 6.6. Global Artificial Intelligence in Healthcare Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Software
  • Predictive Analytics Software
  • Natural Language Processing (NLP) Software
  • 6.7. Global Artificial Intelligence in Healthcare Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation Services
  • Maintenance And Support Services

7. Artificial Intelligence in Healthcare Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence in Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence in Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence in Healthcare Market

  • 8.1. Asia-Pacific Artificial Intelligence in Healthcare Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence in Healthcare Market

  • 9.1. China Artificial Intelligence in Healthcare Market Overview
  • 9.2. China Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence in Healthcare Market

  • 10.1. India Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence in Healthcare Market

  • 11.1. Japan Artificial Intelligence in Healthcare Market Overview
  • 11.2. Japan Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence in Healthcare Market

  • 12.1. Australia Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence in Healthcare Market

  • 13.1. Indonesia Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence in Healthcare Market

  • 14.1. South Korea Artificial Intelligence in Healthcare Market Overview
  • 14.2. South Korea Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence in Healthcare Market

  • 15.1. Western Europe Artificial Intelligence in Healthcare Market Overview
  • 15.2. Western Europe Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence in Healthcare Market

  • 16.1. UK Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence in Healthcare Market

  • 17.1. Germany Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence in Healthcare Market

  • 18.1. France Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence in Healthcare Market

  • 19.1. Italy Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence in Healthcare Market

  • 20.1. Spain Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence in Healthcare Market

  • 21.1. Eastern Europe Artificial Intelligence in Healthcare Market Overview
  • 21.2. Eastern Europe Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence in Healthcare Market

  • 22.1. Russia Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence in Healthcare Market

  • 23.1. North America Artificial Intelligence in Healthcare Market Overview
  • 23.2. North America Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence in Healthcare Market

  • 24.1. USA Artificial Intelligence in Healthcare Market Overview
  • 24.2. USA Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence in Healthcare Market

  • 25.1. Canada Artificial Intelligence in Healthcare Market Overview
  • 25.2. Canada Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence in Healthcare Market

  • 26.1. South America Artificial Intelligence in Healthcare Market Overview
  • 26.2. South America Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence in Healthcare Market

  • 27.1. Brazil Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence in Healthcare Market

  • 28.1. Middle East Artificial Intelligence in Healthcare Market Overview
  • 28.2. Middle East Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence in Healthcare Market

  • 29.1. Africa Artificial Intelligence in Healthcare Market Overview
  • 29.2. Africa Artificial Intelligence in Healthcare Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence in Healthcare Market, Segmentation By Algorithm, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence in Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence in Healthcare Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence in Healthcare Market Competitive Landscape
  • 30.2. Artificial Intelligence in Healthcare Market Company Profiles
    • 30.2.1. IBM Watson Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Nuance Communications, Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alphabet Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Concreto HealthAI Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence in Healthcare Market Other Major And Innovative Companies

  • 31.1. PathAI
  • 31.2. XtalPi
  • 31.3. Benevolent AI
  • 31.4. Exscientia
  • 31.5. OWKIN
  • 31.6. LiveHealth
  • 31.7. ChironX
  • 31.8. Consure Medical
  • 31.9. Predible Health
  • 31.10. Lybrate
  • 31.11. Artelus
  • 31.12. OncoStem Qure.ai
  • 31.13. Jiaxing Taimei Medical Technology
  • 31.14. Ping An Health Medical Technology
  • 31.15. YITU

32. Global Artificial Intelligence in Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence in Healthcare Market

34. Recent Developments In The Artificial Intelligence in Healthcare Market

35. Artificial Intelligence in Healthcare Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence in Healthcare Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence in Healthcare Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence in Healthcare Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer